Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population
Interventional
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Adherence to CaracĀ® in subjects with moderate to severe actinic keratosis.
12 weeks
No
Steve Feldman, MD, PhD
Principal Investigator
Wake Forest University
United States: Institutional Review Board
00000156
NCT00696488
April 2007
October 2008
Name | Location |
---|---|
Wake Forest University Health Sciences Dermatology | Winston Salem, North Carolina 27157 |